In vivo transfection of cis element "decoy" against nuclear factor-kappaB binding site prevents myocardial infarction.
about
Tea polyphenols regulate key mediators on inflammatory cardiovascular diseasesmiR-605 joins p53 network to form a p53:miR-605:Mdm2 positive feedback loop in response to stressA nucleoprotein complex containing Sp1, C/EBP beta, and HMGI-Y controls human insulin receptor gene transcriptionAngiotensin II induced inflammation in the kidney and in the heart of double transgenic ratsTargeted disruption of transcriptional regulatory function of p53 by a novel efficient method for introducing a decoy oligonucleotide into nuclei.The function of miRNA in cardiac hypertrophyUse of cell permeable NBD peptides for suppression of inflammationHypoxia induces expression of the chemokines monocyte chemoattractant protein-1 (MCP-1) and IL-8 in human dermal fibroblastsThe Y-box-binding protein, YB1, is a potential negative regulator of the p53 tumor suppressorRepression of miR-142 by p300 and MAPK is required for survival signalling via gp130 during adaptive hypertrophyNOD1 activation induces cardiac dysfunction and modulates cardiac fibrosis and cardiomyocyte apoptosisMicroRNA-682-mediated downregulation of PTEN in intestinal epithelial cells ameliorates intestinal ischemia-reperfusion injuryLeukocyte-endothelial cell adhesion: avenues for therapeutic interventionNuclear factor-kappaB activation via tyrosine phosphorylation of inhibitor kappaB-alpha is crucial for ciliary neurotrophic factor-promoted neurite growth from developing neurons.Yeast genetic selections to optimize RNA decoys for transcription factor NF-kappa BMicroRNA-125b protects against myocardial ischaemia/reperfusion injury via targeting p53-mediated apoptotic signalling and TRAF6.Panaxatriol saponins attenuated oxygen-glucose deprivation injury in PC12 cells via activation of PI3K/Akt and Nrf2 signaling pathway.Anti-inflammatory properties of C-Peptide.Beneficial effects of muscone on cardiac remodeling in a mouse model of myocardial infarctionCD40 and B chronic lymphocytic leukemia cell response to fludarabine: the influence of NF-kappaB/Rel transcription factors on chemotherapy-induced apoptosis.Targeted deletion of NF-kappaB p50 diminishes the cardioprotection of histone deacetylase inhibitionTranscriptional and post-transcriptional mechanisms for oncogenic overexpression of ether à go-go K+ channel.The impact of molecular medicine upon early cardiovascular drug development.Nuclear factor-kappa B decoy suppresses nerve injury and improves mechanical allodynia and thermal hyperalgesia in a rat lumbar disc herniation model.The cytoprotective effects of tumor necrosis factor are conveyed through tumor necrosis factor receptor-associated factor 2 in the heart.Thymidine phosphorylase inhibits vascular smooth muscle cell proliferation via upregulation of STAT3TLR2 ligands induce cardioprotection against ischaemia/reperfusion injury through a PI3K/Akt-dependent mechanismTherapeutic potential of neurotrophic factors and neural stem cells against ischemic brain injury.Therapeutic applications of transcription factor decoy oligonucleotidesTreatment of murine Th1- and Th2-mediated inflammatory bowel disease with NF-kappa B decoy oligonucleotides.Inhibiting NF-κB activation by small molecules as a therapeutic strategy.Evaluation of behavior and expression of receptor activator of nuclear factor-kappa B ligand in dorsal root Ganglia after sciatic nerve compression and application of nucleus pulposus in ratsSmall RNA- and DNA-based gene therapy for the treatment of liver cirrhosis, where we are?Genetic targeting for cardiovascular therapeutics: are we near the summit or just beginning the climb?Impaired autophagy contributes to adverse cardiac remodeling in acute myocardial infarction.Role of nuclear factor-kappa B (NF-kappa B) in inflammation, periodontitis, and atherogenesis.Molecular medicine for the cardiac surgeon.Polyethylenimine/oligonucleotide polyplexes investigated by fluorescence resonance energy transfer and fluorescence anisotropyInhibitory effect of ribbon-type NF-kappaB decoy oligodeoxynucleotides on osteoclast induction and activity in vitro and in vivoHepatocyte growth factor prevents lupus nephritis in a murine lupus model of chronic graft-versus-host disease
P2860
Q21342761-BB798C8E-E1CC-40D5-9A19-64D5DB1F70B2Q24630464-2D9580BC-7232-478A-B418-B6343CF5C168Q24685071-FF310A43-34EB-4D60-9F22-FB372801FF9CQ24800784-ABA967F3-54AE-4796-8B89-1BD1DEDB2283Q24810050-994C6390-4FA5-4193-8275-22A982D9F7ADQ26828961-A5B1874C-ECB0-44C3-BC43-4F83119A804AQ28268290-632B508C-30A9-409C-8F34-707F8DBD7626Q28347182-96931EE5-0CD8-47D6-B7F8-6455F45734CBQ28564441-F40B69D8-FADD-47A0-87F3-5C49CD9CC2E7Q28571438-F4105002-E5A1-4A30-8E6C-C9D68FD42741Q28579741-6769E59A-302C-47AA-A49A-7EC8AD6CCA25Q28833609-589F3BCD-E225-4582-AF50-3ED0CA03BDEDQ29544231-2CF7B08C-8091-4774-B09E-C5735E3181F9Q30460154-1BF69975-39C2-42EE-A1BD-C1EF58EA01D8Q30897995-348AF0F7-54C3-4395-B319-877847A175D8Q33648129-56A2DADC-D232-4EFA-BD61-2E6C06661FE1Q33681841-C77DDB90-0A4D-42BF-BE13-54F1996566F6Q33682573-0AA54449-27DA-4518-B1CD-5DC86EC1C0DAQ33811214-4D3225D8-8E4D-4D75-A4D4-553727D7533EQ33837951-91E87F95-4352-4C4D-8032-B520EBA246C0Q33917016-2F9B09A5-639C-4ACA-8593-433A39A643C1Q33927117-AD341F4E-3553-4786-ACF6-92177249089DQ33962018-DFFFE182-2CFA-4233-9B73-56AB56027D43Q33972984-615C7DA0-9788-4BFB-8E8C-75B295EF1B69Q34022068-62A3743E-8947-4928-8DB3-2FA530B25844Q34046503-18AEC798-7251-420B-8185-673D06C40D7EQ34062721-CB7878C7-FAE2-4078-B19D-CA8487369370Q34067458-2BD2F061-ACA9-4E6B-88A7-B359C4AA7E51Q34078075-88D35760-0E30-42BC-8F1A-3F1720EBBC26Q34084499-1D4DB417-D765-4D8E-8277-F6BCA50CAC72Q34205025-85541B84-B1F0-4A1A-939C-A17E6FE86E04Q34390156-704E0842-6B43-41CC-AB95-FDC8A2E4D746Q34405044-A14535D1-98AD-4805-8E94-DC66519E917FQ34482530-FF59C23D-E684-4346-95AF-8DA5192E882AQ34542224-A93CDEB9-A045-40F9-82FA-74223D8D1907Q34557691-21BFF3D9-8B9F-4220-A6D0-E5E598F5E1D8Q34803109-F8F4F471-C8C6-4986-867B-7FF3B8BDF29BQ34805862-DACBE0F8-E797-4C08-91F0-58D12D510262Q35605522-2365CD1E-DE7E-44D9-B3A2-ADC213CD0491Q35605610-D5BE6025-3678-4BEE-B5C7-F281E274DD1E
P2860
In vivo transfection of cis element "decoy" against nuclear factor-kappaB binding site prevents myocardial infarction.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
In vivo transfection of cis el ...... revents myocardial infarction.
@en
type
label
In vivo transfection of cis el ...... revents myocardial infarction.
@en
prefLabel
In vivo transfection of cis el ...... revents myocardial infarction.
@en
P2093
P356
P1433
P1476
In vivo transfection of cis el ...... revents myocardial infarction.
@en
P2093
Moriguchi A
Morishita R
Sugimoto T
P2888
P304
P356
10.1038/NM0897-894
P407
P577
1997-08-01T00:00:00Z
P6179
1042702669